Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kehuang capsule for liver fibrosis in chronic hepatitis B
ChiCTR2200063567Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Kehuang Capsules in hepatic fibrosis and Chronic Hepatitis B (CHB) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Transient elastography liver stiffness measurement at Week 48. Planned start May 2022; status: not yet recruiting.
02
Drugs
Kehuang Capsules
03
Conditions
hepatic fibrosisChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2200063567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063567.